Home › Companies › Cabaletta Bio, Inc. › 2025-2026
At Cabaletta Bio, Inc.'s shareholder meeting held June 9, 2026, in the 2025-2026 proxy season, 82 asset managers reported how they voted in their SEC Form N-PX filings, covering 347 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of our named executive officers. — FOR was 51.3% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Cabaletta Bio, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 11, 2026.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Cabaletta Bio, Inc.’s Form 8-K, filed June 11, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 9, 2026: 6 items on Cabaletta Bio, Inc.’s Form 8-K, filed June 11, 2026: 1 approved · 5 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Cabaletta Bio, Inc. in the interactive database Compare manager voting policies
These tallies are Cabaletta Bio, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 11, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Scott Brun, M.D. | 39,537,359 | -- | -- | 14,048,767 | 28,730,239 | 74% | Not verified | — |
| Elect Director: Shawn Tomasello, MBA | 28,606,240 | -- | -- | 24,979,886 | 28,730,239 | 53.4% | Not verified | — |
| Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, recommended for ratification in Proposal 2 at the Annual M | 82,076,950 | 198,605 | 40,810 | -- | 0 | 99.7% | Not verified | — |
| As set forth in the Supplement, the Board of Directors withdrew Proposal 3, the Plan Amendment Proposal, from stockholder consideration at the Annual Meeting. Accordingly, proxy cards or voting instructions received with direction on Propos | 80,398,225 | 1,803,500 | 114,640 | -- | 0 | 98% | Not verified | — |
| Company's stockholders approved, by non-binding advisory vote, the compensation of the Company's named executive officers in Proposal 5. | 27,490,145 | 26,048,082 | 47,899 | -- | 28,730,239 | 51.3% | Not verified | — |
| 6. Deemed not necessary because there was a quorum present and there were sufficient proxies at the time of the Annual Meeting to approve the Charter Amendment Proposal, it | 48,403,739 | 33,841,505 | 71,121 | -- | 0 | 59% | Approved | — |
Source: Cabaletta Bio, Inc., Form 8-K, filed with the SEC on June 11, 2026 — read the filing on EDGAR.
Each item below shows how the 82 asset managers that disclosed a Cabaletta Bio, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Cabaletta Bio, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
Description as filed by funds: To elect two class I directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Scott Brun, M.D.
Cabaletta Bio, Inc.’s own tally for this item (“Elect Director: Scott Brun, M.D.”): 39,537,359 for, 14,048,767 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 19 asset managers below reported 12,718,193 for, 383,784 withheld, 24 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,104,994 | 0 | 0 | 0 | For |
| Prudential/PGIM | 3,518,102 | 0 | 0 | 0 | For |
| Vanguard | 2,508,622 | 0 | 24 | 7,074 | For |
| Northwestern Mutual | 318,113 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 207,898 | Withhold |
| Fidelity | 124,866 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 101,318 | Withhold |
| Jacob Funds Inc. | 60,000 | 0 | 0 | 0 | For |
| Charles Schwab | 50,606 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 27,243 | Withhold |
| Goldman Sachs | 20,377 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 16,320 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 15,600 | Withhold |
| John Hancock | 12,513 | 0 | 0 | 1,604 | Mixed |
| ProShares | 0 | 0 | 0 | 4,114 | Withhold |
| Invesco | 0 | 0 | 0 | 1,920 | Withhold |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 504 | Withhold |
| Victory Capital | 0 | 0 | 0 | 97 | Withhold |
| Dimensional | 0 | 0 | 0 | 92 | Withhold |
Combines 3 wordings of this item as funds reported it.
53.4% Majority: yes · of votes cast
Description as filed by funds: To elect two class I directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Shawn Tomasello, MBA
Cabaletta Bio, Inc.’s own tally for this item (“Elect Director: Shawn Tomasello, MBA”): 28,606,240 for, 24,979,886 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 53.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 19 asset managers below reported 6,512,034 for, 6,589,923 withheld, 45 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 6,104,994 | Withhold |
| Prudential/PGIM | 3,518,102 | 0 | 0 | 0 | For |
| Vanguard | 2,513,361 | 0 | 45 | 2,315 | For |
| Northwestern Mutual | 0 | 0 | 0 | 318,113 | Withhold |
| BlackRock | 207,898 | 0 | 0 | 0 | For |
| Fidelity | 124,866 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 101,318 | Withhold |
| Jacob Funds Inc. | 60,000 | 0 | 0 | 0 | For |
| Charles Schwab | 50,606 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 27,243 | Withhold |
| Goldman Sachs | 20,377 | 0 | 0 | 0 | For |
| Equitable | 16,320 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 15,600 | Withhold |
| John Hancock | 0 | 0 | 0 | 14,117 | Withhold |
| ProShares | 0 | 0 | 0 | 4,114 | Withhold |
| Invesco | 0 | 0 | 0 | 1,920 | Withhold |
| Advisors' Inner Circle Fund III | 504 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 97 | Withhold |
| Dimensional | 0 | 0 | 0 | 92 | Withhold |
99.5% of fund votes cast · no official result
Description as filed by funds: TO APPROVE AN AMENDMENT TO OUR THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 300,000,000 TO 600,000,000.
The 19 asset managers below reported 13,042,000 for, 60,001 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,104,994 | 0 | 0 | 0 | For |
| Prudential/PGIM | 3,518,102 | 0 | 0 | 0 | For |
| Vanguard | 2,515,719 | 1 | 0 | 0 | For |
| Northwestern Mutual | 318,113 | 0 | 0 | 0 | For |
| BlackRock | 207,898 | 0 | 0 | 0 | For |
| Fidelity | 124,866 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 101,318 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 0 | 60,000 | 0 | 0 | Against |
| Charles Schwab | 50,606 | 0 | 0 | 0 | For |
| American Century | 27,243 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,377 | 0 | 0 | 0 | For |
| Equitable | 16,320 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 15,600 | 0 | 0 | 0 | For |
| John Hancock | 14,117 | 0 | 0 | 0 | For |
| ProShares | 4,114 | 0 | 0 | 0 | For |
| Invesco | 1,920 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 504 | 0 | 0 | 0 | For |
| Victory Capital | 97 | 0 | 0 | 0 | For |
| Dimensional | 92 | 0 | 0 | 0 | For |
28% of fund votes cast · no official result
Description as filed by funds: TO APPROVE A PROPOSAL TO ADJOURN THE ANNUAL MEETING TO A LATER DATE OR DATES, IF NECESSARY OR APPROPRIATE, TO PERMIT FURTHER SOLICITATION AND VOTE OF PROXIES IN THE EVENT THAT THERE ARE INSUFFICIENT VOTES FOR, OR OTHERWISE IN CONNECTION WITH, THE APPROVAL OF PROPOSAL 3 AND PROPOSAL 4.
The 19 asset managers below reported 3,674,036 for, 9,427,965 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 6,104,994 | 0 | 0 | Against |
| Prudential/PGIM | 3,518,102 | 0 | 0 | 0 | For |
| Vanguard | 8,267 | 2,507,453 | 0 | 0 | Against |
| Northwestern Mutual | 0 | 318,113 | 0 | 0 | Against |
| BlackRock | 0 | 207,898 | 0 | 0 | Against |
| Fidelity | 124,866 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 101,318 | 0 | 0 | Against |
| Jacob Funds Inc. | 0 | 60,000 | 0 | 0 | Against |
| Charles Schwab | 0 | 50,606 | 0 | 0 | Against |
| American Century | 0 | 27,243 | 0 | 0 | Against |
| Goldman Sachs | 20,377 | 0 | 0 | 0 | For |
| Equitable | 0 | 16,320 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 15,600 | 0 | 0 | Against |
| John Hancock | 0 | 14,117 | 0 | 0 | Against |
| ProShares | 0 | 4,114 | 0 | 0 | Against |
| Invesco | 1,920 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 504 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 97 | 0 | 0 | Against |
| Dimensional | 0 | 92 | 0 | 0 | Against |
98% of fund votes cast · no official result
Description as filed by funds: TO APPROVE AN AMENDMENT TO THE CABALETTA BIO, INC. 2019 STOCK OPTION AND INCENTIVE PLAN.
The 8 asset managers below reported 3,521,604 for, 66,264 against, 274,993 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Prudential/PGIM | 3,518,102 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 207,898 | 0 | Abstain |
| Jacob Funds Inc. | 0 | 60,000 | 0 | 0 | Against |
| Charles Schwab | 0 | 0 | 50,606 | 0 | Abstain |
| John Hancock | 0 | 0 | 14,117 | 0 | Abstain |
| Vanguard | 3,502 | 4,760 | 2,372 | 0 | Mixed |
| Rangeley Capital, LLC | 0 | 1,000 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 0 | 504 | 0 | 0 | Against |
Combines 8 wordings of this item as funds reported it.
51.3% Majority: yes · of votes cast
Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of our named executive officers.
Cabaletta Bio, Inc.’s own tally for this item (“The Company's stockholders approved, by non-binding advisory vote, the compensation of the Company's named executive officers in Proposal 5.”): 27,490,145 for, 26,048,082 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 51.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 6,104,994 | 0 | 0 | Against |
| Prudential/PGIM | 3,518,102 | 0 | 0 | 0 | For |
| Vanguard | 2,515,674 | 46 | 0 | 0 | For |
| Northwestern Mutual | 0 | 318,113 | 0 | 0 | Against |
| BlackRock | 0 | 207,898 | 0 | 0 | Against |
| Fidelity | 124,866 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 101,318 | 0 | 0 | Against |
| Jacob Funds Inc. | 0 | 60,000 | 0 | 0 | Against |
| Charles Schwab | 50,606 | 0 | 0 | 0 | For |
| American Century | 0 | 27,243 | 0 | 0 | Against |
| Goldman Sachs | 20,377 | 0 | 0 | 0 | For |
| Equitable | 0 | 16,320 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 15,600 | 0 | 0 | Against |
| John Hancock | 0 | 14,117 | 0 | 0 | Against |
| ProShares | 0 | 4,114 | 0 | 0 | Against |
| Invesco | 0 | 1,920 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 0 | 504 | 0 | 0 | Against |
| Victory Capital | 0 | 97 | 0 | 0 | Against |
| Dimensional | 0 | 92 | 0 | 0 | Against |
Fund voting reports, all 19 managers: 6,229,625 for, 6,872,376 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 11,122,335 | 0 | 0 | Against |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0 | 8,829,758 | 0 | 0 | Against |
| Cormorant Asset Management, LP | 5,328,601 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 4,987,255 | 0 | 0 | 0 | For |
| Bain Capital Life Sciences Investors, LLC | 4,260,888 | 0 | 0 | 0 | For |
| Two Sigma | 0 | 1,670,150 | 0 | 0 | Against |
| Woodline Partners LP | 910,611 | 0 | 0 | 0 | For |
| Vanguard | 605,942 | 7,541 | 0 | 0 | For |
| Raiffeisen Bank International AG | 450,000 | 0 | 0 | 0 | For |
| Burkehill Global Management, LP | 444,851 | 0 | 0 | 0 | For |
| Renaissance | 0 | 364,071 | 0 | 0 | Against |
| BlackRock | 8,495 | 300,442 | 0 | 0 | Against |
| 683 Capital Management, LLC | 0 | 225,000 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 200,878 | 0 | 0 | 0 | For |
| DE Shaw | 0 | 192,312 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 145,042 | 0 | 0 | 0 | For |
| Hudson Bay Capital Management LP | 0 | 140,613 | 0 | 0 | Against |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 114,518 | 0 | 0 | Against |
| Northern Trust | 0 | 97,925 | 0 | 0 | Against |
| LETKO, BROSSEAU & ASSOCIATES INC | 90,475 | 0 | 0 | 0 | For |
| Dimensional | 0 | 67,659 | 0 | 0 | Against |
| Charles Schwab | 50,824 | 0 | 0 | 0 | For |
| Stonepine Capital Management, LLC | 50,000 | 0 | 0 | 0 | For |
| Point72 | 0 | 35,817 | 0 | 0 | Against |
| State Street | 34,648 | 983 | 0 | 0 | For |
Institutional-manager reports, all 69 managers: 17,766,162 for, 23,269,853 against. Showing the 25 largest; every one is in the interactive database (link above).
99.7% Majority: yes · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
Cabaletta Bio, Inc.’s own tally for this item (“The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, recommended for ratification in Propos”): 82,076,950 for, 198,605 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 19 asset managers below reported 13,102,001 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,104,994 | 0 | 0 | 0 | For |
| Prudential/PGIM | 3,518,102 | 0 | 0 | 0 | For |
| Vanguard | 2,515,720 | 0 | 0 | 0 | For |
| Northwestern Mutual | 318,113 | 0 | 0 | 0 | For |
| BlackRock | 207,898 | 0 | 0 | 0 | For |
| Fidelity | 124,866 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 101,318 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 60,000 | 0 | 0 | 0 | For |
| Charles Schwab | 50,606 | 0 | 0 | 0 | For |
| American Century | 27,243 | 0 | 0 | 0 | For |
| Goldman Sachs | 20,377 | 0 | 0 | 0 | For |
| Equitable | 16,320 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 15,600 | 0 | 0 | 0 | For |
| John Hancock | 14,117 | 0 | 0 | 0 | For |
| ProShares | 4,114 | 0 | 0 | 0 | For |
| Invesco | 1,920 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 504 | 0 | 0 | 0 | For |
| Victory Capital | 97 | 0 | 0 | 0 | For |
| Dimensional | 92 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 163,054,796 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 3.74% |
| 2 | Prudential/PGIM | 2.16% |
| 3 | Vanguard | 1.54% |
| 4 | Northwestern Mutual | 0.20% |
| 5 | BlackRock | 0.13% |
| 6 | Fidelity | 0.08% |
| 7 | BRIDGEWAY FUNDS INC | 0.06% |
| 8 | Jacob Funds Inc. | 0.04% |
| 9 | Charles Schwab | 0.03% |
| 10 | American Century | 0.02% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 6.82% |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.42% |
| 3 | Cormorant Asset Management, LP | 3.27% |
| 4 | JENNISON ASSOCIATES LLC | 3.06% |
| 5 | Bain Capital Life Sciences Investors, LLC | 2.61% |
| 6 | Two Sigma | 1.02% |
| 7 | Woodline Partners LP | 0.56% |
| 8 | Vanguard | 0.38% |
| 9 | Raiffeisen Bank International AG | 0.28% |
| 10 | Burkehill Global Management, LP | 0.27% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Jennison Associates LLC | 14.88% | 13G |
| PRUDENTIAL FINANCIAL INC | 14.88% | 13G |
| T. Rowe Price Investment Management, Inc. | 11.57% | 13G |
| Bain Capital Life Sciences Opportunities III, LP | 10.57% | 13G |
| Adage Capital Management, L.P. | 8.69% | 13G |
| Cormorant Asset Management, LP | 6.13% | 13G |
| Norges Bank | 5.38% | 13G |
| Vanguard Capital Management | 5.02% | 13G |
| Millennium Management | 3.62% | 13F |
| Alyeska Investment Group, L.P. | 2.76% | 13G |
Percentages above are of 163,054,796 shares outstanding, as reported by Cabaletta Bio, Inc. on its Form 10-Q dated May 7, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Cabaletta Bio, Inc.’s 10-Q dated May 7, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
Cabaletta Bio, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
proxyvotesnow.com, “Cabaletta Bio (CABA) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/cabaletta-bio-inc/2026 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.